What was Park Medi World's revenue in Q4 FY26?

Park Medi World reported revenue of ₹460 Cr in Q4 FY26, a +21% change year-over-year.

Did Park Medi World management deliver on previous promises?

Scorecard data is being built as historical quarters are processed.

Park Medi World Q4 FY26 Research Workspace: Revenue ₹460 Cr (+21%)

Q: What guidance did Park Medi World management give?

Bed capacity target of 5,460 by March 2028: Company plans to add ~1,500 beds over next two years with a total capex of ~₹500 Cr, funded through internal accruals and existing cash.

Revenue ₹460 Cr +21%

EBITDA ₹444 Cr +20%

PAT ₹77 Cr +27%

EBITDA Margin 28%

Duration 75 min

Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Park Medi World delivered its strongest year ever in FY26, with revenue of ₹1,679 Cr (+21% YoY), EBITDA of ₹444 Cr (+20% YoY), and PAT of ₹274 Cr (+27% YoY). Q4 revenue grew 30% YoY to ₹460 Cr, with EBITDA margin expanding 268 bps to 28%. The stellar performance was driven by record patient volumes (IPD +18% YoY to 95,525, OPD +22% YoY to 7.78 lakh), occupancy improvement to 64.1% (+244 bps), and a deliberate shift toward high-end specialties (56.9% of revenue, +316 bps). The company added 610 beds during the year, taking total capacity to 3,610 beds, and plans to reach 5,460 beds by March 2028 with a capex of ~₹500 Cr over two years. Management guided for a CGHS rate hike benefit of 5-6% to revenue in FY27 and expects margins to remain range-bound. Key risk: receivable days at 129 remain elevated due to government payment cycles, though improving.

Risks4 trackedTranscriptfull text

Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Elevated receivable days from government payers

View Risks →

≡Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Total Beds 3,610

+610 beds YoY

Largest single-year capacity addition; includes new units in Bathinda (250 beds) and Agra (350 beds).

Occupancy Rate 64.1%

+244 bps YoY

Full-year occupancy improved driven by higher patient volumes and ramp-up of new units.

IPD Volume 95,525

+18% YoY

Record inpatient volume reflecting deepening trust and network expansion.

High-End Specialty Revenue Share 56.9%

+316 bps YoY

Shift towards cardiology, oncology, neurology, orthopedics, etc., driving ARPU and margins.

Fast read

Guidance and risk preview

Top guidance Bed capacity target of 5,460 by March 2028

Company plans to add ~1,500 beds over next two years with a total capex of ~₹500 Cr, funded through internal accruals and existing cash.

Top risk Elevated receivable days from government payers

92% of debtors are from central government schemes; receivable days improved to 129 but remain high.